 Home > Active Ingredient News > Infection > Crit Care: Anti-fungal strategy for the prevention of COVID-19-related pulmonary aspergillosis in critically ill patients

Crit Care: Anti-fungal strategy for the prevention of COVID-19-related pulmonary aspergillosis in critically ill patients

 Last Update: 2021-09-19
 Source: Internet
 Author: User

Tags

blue care demand

nano 10 9

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Coronavirus disease 19 ( COVID-19 ) related pulmonary aspergillosis (CAPA) has become an important fungal complication in patients with severe acute respiratory failure (ARF) related to COVID-19
.

So far, whether active antifungal prophylaxis (MAFP) can prevent CAPA is still unclear

COVID-19 prevention

Recently, a research article was published in Critical Care, an authoritative journal in the field of critical care medicine.

In this observational study, researchers included ARF related to COVID-19 from September 1, 2020 to May 1, 2021.

consensus

The researchers enrolled 132 patients, of which 75 (57%) received antifungal prophylaxis (98% posaconazole)
.

After an average of six days after ICU admission, diagnosis out of the 10 cases CAPA case

Original source:

Stefan Hatzl.

et al.
Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study .
Critical Care.
2021.
https://ccforum.

Antifungal prophylaxis for prevention of COVID-19 -associated pulmonary aspergillosis in critically ill patients: an observational study in this message

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Sodium benzoate CAS No.532-32-1

CAS No.: 532-32-1

$1380/MT FOB

Api Powder Ketoconazole 98% Powder KETOCONAZOLE API POWDER

CAS No.: 65277-42-1

Pharmacy Grade

$3-3.2/KG FOB

High Purity Trimethoprim CAS 738-70-5 for Bacterial Infections

CAS No.: 738-70-5

Chemical Grade

$3.5-4/MT FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.